Senti Biosciences is trading 8.4% up today at $0.37 amid a modest rebound from last week’s biotech sector weakness.
- There are no fresh company-specific filings, press releases, or analyst calls reported this morning to account for the price action.
- The move appears to be a low-priced biotech stock bouncing in tandem with a broadly positive equity market rather than reacting to a distinct corporate event.